Page 2 - கேன் கச்சிஅத்தூ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேன் கச்சிஅத்தூ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேன் கச்சிஅத்தூ Today - Breaking & Trending Today

BioCryst Pharmaceuticals (BCRX) Q1 2021 Earnings Call Transcript


BioCryst Pharmaceuticals (BCRX) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
BioCryst Pharmaceuticals (NASDAQ: BCRX)
Ladies and gentlemen, thank you for standing by, and welcome to the BioCryst s first-quarter 2021 earnings call. [Operator instructions] I would now like to hand the conference over to your speaker today, Mr. John Bluth of BioCryst. John, the floor is yours.
John Bluth
Senior Vice President, Investor Relations and Corporate Communications
Thanks, Jay. Good morning and welcome to BioCryst s first-quarter 2021 corporate update and financial results conference call. Today s press release is available on our website. Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; and chief commercial officer, Charlie Gayer; chief medical officer, Dr. ....

United Kingdom , John Bluth , Allen Hodges , Bill Sheridan , Kenny Chan , Anthony Doyle , Charlie Gayer , Gena Wang , Kenny Chan Jefferies , Jessica Fye , Megan Sniecinski , Brian Abrahams , Liisa Bayko , Serge Belanger , America Merrill Lynch , Alan Hodges , Jonathan Wolleben , Maury Raycroft , Liisa Bayko Evercore , Helen Thackray , Ron Dullinger , Jon Stonehouse , Tazeen Ahmad , Serge Belanger Needham Company Analyst , Exchange Commission , Biocryst Pharmaceuticals ,

Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript


Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)
Q1 2021 Earnings Call
Operator
Welcome to the Jazz Pharmaceuticals PLC First Quarter 2021 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Andrea Flynn, Head Investor Relations at Jazz Pharmaceuticals. Thank you. Please go ahead.SPONSORED:
10 stocks we like better than Jazz Pharmaceuticals
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market.   ....

United States , David Risinger , Brucec Cozadd , Gary Nachman , Jason Gerberry , Kim Sablich , Marc Goodman Leerink , Graig Suvannavejh , Balaji Prasad Barclays , Jessica Fye , Anne Borgman , Annabel Samimy , Balaji Prasad , Marc Goodman , David Steinberg , Dan Swisher , Bruce Cozadd , America Merrill Lynch , Annabel Samimy Stifel Nicolaus , Andrean Flynn , Andrea Flynn , Piper Sandler , Gregg Gilbert , Phil Jochelson , David Risinger Morgan Stanley , Esther Rajavelu ,

Horizon Therapeutics PLC (HZNP) Q1 2021 Earnings Call Transcript


Horizon Therapeutics PLC (HZNP) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Horizon Therapeutics PLC (NASDAQ: HZNP)
Popular Searches
Operator
Good morning and thank you for standing by, and welcome to the Horizon Therapeutics PLC First Quarter 2021 Earnings Conference Call. As a reminder, today s conference call is being recorded.
I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.SPONSORED:
10 stocks we like better than Horizon Therapeutics
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

White House , District Of Columbia , United States , Liz Thompson , David Risinger , Dana Flanders Guggenheim , Melina Santoro , Dave Risinger , Akash Tewari Wolfe , Gary Nachman , Jason Gerberry , Melina Santoro Morgan Stanley , Annabel Samimy , Annabel Samimy Stifel , David Steinberg , Neuroimmunology Neuroinflammation , Viela Bio , Chris Schott Jpmorgan , Tim Walbert , Akash Tewari , Piper Sandler , Paul Hoelscher , Chris Schott , Dana Flanders , Tina Ventura , David Amsellem ,

Aurinia Pharmaceuticals Inc (AUPH) Q4 2020 Earnings Call Transcript


Operator
Greetings, and welcome to the Aurinia Year-end 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is recorded. It s now my pleasure to turn the call over to Glenn Schulman, Senior Vice President, Investor Relations. Please go ahead, sir.
Glenn Schulman
Senior Vice President, Corporate Communications and Investor Relations
Thank you, Kevin, and good afternoon, everyone. I m pleased to welcome you to today s call discussing Aurinia s fourth quarter and year-end financial results. Joining me on the call this afternoon are Peter Greenleaf, President and CEO of Aurinia; Neil Solomons, our Chief Medical Officer; Max Colao, Chief Commercial Officer; and Joe Miller, our Chief Financial Officer. This afternoon, just after 4:00 p.m., we issued a press release announcing our financial results and recent operational highlights, which is accessible from our website at www.auriniapharma.com and has been filed on a Form 8-K ....

United States , Switzerland General , Peter Greenleaf , Glenn Schulman , Maury Raycroft , Neil Solomons , Max Colao , Alethia Young , Justin Kim , Emily Cantor Fitzgerald , Joe Miller , Otsuka Pharmaceuticals , Aurinia Pharmaceuticals Inc , Aurinia Alliance , Maurice Thomas Raycroft Jefferies , Exchange Commission , Cowen Company , Justin Alexander Kim Oppenheimer Co , Cantor Fitzgerald , Corporate Communications , Devices Agency , Company Analyst , Aurinia Year End , Results Conference , Senior Vice President , Vice President ,